
    
      1. Cross-section study: normal/prediabetes/drug na√Øve type2 diabetes: compare microbiota
           using metagenomic sequencing among three groups.

        2. Observational prospective study: metformin/sodium glucose co-transporter 2 (SGLT2)
           inhibitor/ezetimibe: compare microbiota using metagenomic sequencing before and after
           drug treatment.
    
  